11/14
04:09 pm
envb
Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results [Yahoo! Finance]
High
Report
Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results [Yahoo! Finance]
11/14
04:05 pm
envb
Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results
Medium
Report
Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results
11/12
09:00 am
envb
Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002
High
Report
Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002
11/4
09:00 am
envb
Enveric Biosciences Announces Broad Range of Patent Issuances
Medium
Report
Enveric Biosciences Announces Broad Range of Patent Issuances
10/15
08:00 am
envb
Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003
High
Report
Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003
9/26
08:30 am
envb
Enveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial Workshop
Medium
Report
Enveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial Workshop
9/25
08:30 am
envb
Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit
Medium
Report
Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit
9/4
08:00 am
envb
Enveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Low
Report
Enveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference